Skip to main content
Peijia Medical Limited logo

Peijia Medical Limited — Investor Relations & Filings

Ticker · 9996 ISIN · KYG6981F1090 LEI · 300300VE46IBS1WO9M65 HKEX Manufacturing
Open in API
Filings indexed 259 across all filing types
Latest filing 2026-05-29 Declaration of Voting R…
Country KY Cayman Islands
Listing HKEX 9996

About Peijia Medical Limited

http://www.peijiamedical.com

Peijia Medical Limited is a medical device company specializing in the research, development, manufacturing, and commercialization of high-end interventional procedural medical devices. Its core business is segmented into two high-growth therapeutic areas: transcatheter valve therapeutics for structural heart disease and neurovascular interventions. Within structural heart, Peijia offers a complete portfolio for aortic, mitral, and tricuspid valve replacement and repair, featuring the Taurus Series of transcatheter aortic valve systems, such as TaurusTrio, which addresses aortic regurgitation. The company maintains a strong focus on innovation, exemplified by its Shockwave Valve Treatment System, which aims to pioneer "implant-free" valve therapy and has been fast-tracked through regulatory review. Peijia is positioned as a leading domestic provider in both its primary intervention fields.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 29, 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from the Annual General Meeting of Peijia Medical Limited held on May 29, 2026, detailing vote counts and percentages for each resolution. This clearly matches the definition of a Declaration of Voting Results & Voting Rights Announcement. Therefore, it should be classified as DVA.
2026-05-29 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2026
Regulatory Filings Classification · 95% confidence The document is a monthly return filing for an equity issuer listed on the Hong Kong Stock Exchange, detailing movements in authorized share capital, issued shares, treasury shares, share options, and public float sufficiency confirmation. It includes confirmations pursuant to specific listing rules and is addressed to the exchange. The content is regulatory in nature, reporting share capital and shareholding movements, but it is not a financial report, earnings release, or management discussion. It is a regulatory compliance filing related to share capital and shareholding disclosures. The document is not a report publication announcement, nor a certification letter, but a formal regulatory submission. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-05-07 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 29, 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a "Form of Proxy" for the Annual General Meeting, which is used to solicit shareholder votes and provide information on resolutions to be voted on. This fits the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-23 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 82% confidence The document is the formal notice of the company’s Annual General Meeting, containing the proposed resolutions, explanatory notes, proxy appointment instructions and details for shareholder voting. This type of filing—materials sent to shareholders to provide information on resolutions and solicit their votes—is best categorized as a Proxy Solicitation & Information Statement (PSI).
2026-04-23 English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular issued by the Board to shareholders ahead of the Annual General Meeting. It contains the notice of the AGM, resolutions on general mandates to issue and repurchase shares, re-election of directors, re-appointment of auditor, detailed definitions, explanatory statements and a form of proxy. This is a classic proxy solicitation and information statement rather than a full annual report or earnings release.
2026-04-23 English
Annual Report 2025
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2025' for Peijia Medical Limited. It contains comprehensive sections including a Chairman's Statement, Financial Highlights, Business Highlights, Management Discussion and Analysis, and full consolidated financial statements (Profit or Loss, Financial Position, Cash Flows, etc.). It is clearly the company's official annual report for the fiscal year 2025, not an announcement or summary. FY 2025
2026-04-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.